Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Submitted by
admin
on January 29, 2018 - 11:57pm
Source:
Fierce Pharma
News Tags:
Valeant Pharmaceuticals
Cosmo Pharma
rifamycin SV
IBS-d
Xifaxan
Headline:
Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Do Not Allow Advertisers to Use My Personal information
